ATANIS Biotech’s Financing Round

VISCHER acted as counsel to ATANIS Biotech AG in the financing. ATANIS Biotech AG announced the successful completion of a significant capital increase. iXLife co-led the...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

CODE41 SA’s Tokenized Securities Offering

VISCHER advised CODE41 SA in the process. CODE41 SA, a community-centric Swiss watchmaking company, has increased its share capital by issuing participation certificates in the form...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here